China Biologic Products to Report Second Quarter 2012 Financial Results

BEIJING, August 3, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter 2012 financial results on Thursday, August 9, 2012 after the market closes.

The Company's management will hold a conference call at 8:00 a.m. ET on Friday, August 10, 2012 to discuss second quarter 2012 results. Listeners may access the call by dialing:

U.S. toll free:

+1 866 549 1292

U.K. toll free:

+0 800 279 7818

Mainland China toll free (landline):

800 876 8626 (land line)

Mainland China toll free (mobile):

400 681 6949 (mobile)

Mainland China toll (mobile):

400 889 9481 (mobile)

Hong Kong toll free:

3005 2050

International toll:

+852 3005 2050

Conference ID:

674 477#

A telephone replay will become available beginning two hours after the conclusion of the call and will remain available through August 17, 2012. Listeners may access the replay by dialing:

U.S. toll free:

+1 866 753 0743

U.K. toll free:

+0 808 234 7126

Mainland China:

800 876 5016

Hong Kong:

3005 2020

International toll:

+852 3005 2020

Conference ID:

138 012#

About China Biologic Products, Inc.

China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company's website


China Biologic Products, Inc.
Mr. Ming Yin
Vice President
Phone: +86-10-6598-3099
Email: [email protected]

ICR Inc.
Mr. Rob Koepp
Phone: +86-10-6583-7516 or +1-646-405-5191
E-mail: [email protected]

SOURCE China Biologic Products, Inc.